SL
CLB icon

Savior LLC’s Core Laboratories CLB Stock Holding History

Savior LLC’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-59
Closed -$2K – 292
2021
Q2 		$2K Hold
59
– – ﹤0.01% 713
2021
Q1 		$2K Hold
59
– – ﹤0.01% 730
2020
Q4 		$2K Hold
59
– – ﹤0.01% 703
2020
Q3 		$1K Hold
59
– – ﹤0.01% 741
2020
Q2 		$1K Hold
59
– – ﹤0.01% 707
2020
Q1 		$1K Sell
59
-17
-22% -$475 ﹤0.01% 689
2019
Q4 		$3K Buy
+76
New +$3.42K ﹤0.01% 674

Other funds holding CLB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Savior LLC's CLB Position: Q3 2021 in Review

Savior LLC sold out of Core Laboratories (CLB) in Q3 2021, closing a stake of 59 shares — an estimated $2K sold.

Savior LLC first reported a position in CLB in Q4 2019 and held it in 7 quarters. The position peaked at $3K in Q4 2019. 198 funds tracked by Wall St. Rank hold CLB as of Q3 2021.

  • Savior LLC reported no remaining Core Laboratories position as of Q3 2021 after selling out during the quarter.
  • Savior LLC sold 59 Core Laboratories shares in Q3 2021, an estimated $2K.
  • Savior LLC first reported a position in Core Laboratories in Q4 2019 and held it in 7 quarters.
  • Savior LLC's Core Laboratories position peaked at $3K in Q4 2019.
  • 198 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2021.

Based on Savior LLC's 13F filing for Q3 2021, filed 5 Oct 2021.